Results 181 to 190 of about 3,069,445 (313)

Cancer statistics, 2026: Charting a course for a national cancer research agenda. [PDF]

CA Cancer J Clin
Lara PN, Hershman DL.
europepmc   +1 more source

Novel systems biology tools for the identification of biomarkers and drug targets in cancer research.

, 2022
L. Valcarcel
openalex   +2 more sources

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Cancer research in India: Time to collaborate. [PDF]

Indian J Med Res
Ganesan P.
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

ISG20: The multifaceted 'molecular star' in cancer research (Review). [PDF]

Oncol Rep
Zhu X, Jiang S, Zhang L, Zou S, Zhang H, Zhang J, Chen L, Li H, Zong Z.   +8 more
europepmc   +1 more source

A framework for understanding cancer comparative effectiveness research data needs

, 2012
William R. Carpenter, Anne-Marie Meyer, Amy P. Abernethy, Til Stürmer‎, Michael R. Kosorok   +4 more
openalex   +2 more sources

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Drug repurposing in cancer research: a bibliometric analysis. [PDF]

Discov Oncol
Ndidi US, Ogra IO, Jonathan EU, Iroha OK.   +3 more
europepmc   +1 more source

Understanding Clinical Trials: Advancing Cancer Research and Treatment

, 2023
zulfiqar hassab
openalex   +2 more sources